Shizuoka, Japan

Kazuhisa Fujimoto


Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 118(Granted Patents)


Location History:

  • Shizuoka, JP (1985 - 1987)
  • Kanagawa, JP (1990)

Company Filing History:


Years Active: 1985-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazuhisa Fujimoto: Innovator in Antibiotic Development

Introduction

Kazuhisa Fujimoto is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of antibiotic development, holding a total of 4 patents. His work focuses on compounds derived from microorganisms, showcasing his dedication to advancing medical science.

Latest Patents

Fujimoto's latest patents include Pyrindamycins A and B, as well as duocarmycin A antibiotics. These compounds are produced through the fermentation of microorganisms belonging to the genus Streptomyces. The inventions highlight their antibacterial and anti-tumor activities, making them valuable as medicaments. Additionally, he has developed a pharmacologically acceptable acid addition salt of DC-52, which demonstrates superior stability compared to DC-52 while maintaining the same degree of antitumor activity.

Career Highlights

Throughout his career, Kazuhisa Fujimoto has worked with prominent companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kogyo Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Fujimoto has collaborated with notable coworkers, including Makoto Morimoto and Fusao Tomita. These partnerships have likely enhanced his research and development efforts in the field of antibiotics.

Conclusion

Kazuhisa Fujimoto's contributions to antibiotic development through his innovative patents reflect his commitment to improving healthcare. His work continues to influence the pharmaceutical industry and offers promising solutions for combating bacterial infections and tumors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…